The IL-6/STAT3 Signaling Pathway Is Involved in Radiotherapy-Mediated Upregulation of PD-L1 in Esophageal Cancer.
Radiotherapy significantly upregulates PD-L1 through the IL-6/STAT3 signaling pathway, suggesting that anti-PD-1/PD-L1 immunotherapy combined with radiotherapy may improve the treatment for ESCC.
Authors
- Xuezhou Pang
- Yang Shen (ORCID: https://orcid.org/0000-0001-6607-7818)
- Yu He (ORCID: https://orcid.org/0000-0003-4898-5518)
- Daiyuan Ma (ORCID: https://orcid.org/0000-0002-0757-9487)
- Yichen Zhou (ORCID: https://orcid.org/0000-0002-0596-2087)
- Honglei Zhu
Institutions
- Affiliated Hospital of North Sichuan Medical College (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-01-01
- Citations
- 1
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.01